Although many questions are still left unanswered, and reasons officials believe that they should continue on with the development of the vaccine as stated by David Fedson, a vaccines expert and former professor of medicine at the University of Virginia. "It's a foregone conclusion, if we don't invest in an H1N1 (swine flu) vaccine, then possibly we could have a reappearance of this virus in a mild, moderate, or catastrophic form and we would have absolutely nothing."
To connect with more professionals in the Vaccines field, join our Vaccines Development Forum Group on LinkedIn or join us in Boston September 23-25 for the Vaccines Development Forum.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment